RE: Feedback/Communications23 Mar 2018 13:44
They did say in a recent RNS
"Yantai Cipu has also informed the Company that they are in advanced negotiation with a major medical equipment and pharmaceutical distribution company in China for a collaboration to accelerate and strengthen their market access in the People's Republic of China, Hong Kong, Macau, Taiwan and South Korea (the "Territories"). The Company and Yantai Cipu have agreed that it is in the best interest of the Company and its shareholders to extend the Long Stop Date for the Distribution Agreement until 31 March 2018 to enable the satisfactory completion of the negotiations with the new participant."
I take that as positive if Yantai Cipu are in discussions with a major distributor.
The Chinese Authorities approved the transfer of the �13,500,000 so that is also a positive.
As long as they keep hitting the tech milestones they set themselves. I imagine it will be these that boost the share price for the near future until realistic sales are made.